Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.
Over 6000 publications, 1000 cell lines and primary cells available.
Order by :
Found 89 results :| Cell Line | in vitro in vivo | Delivered Molecule | Reagent | Results & Citations | |
|---|---|---|---|---|---|
| HEK-293F | in vitro | DNA | FectoPRO | Mishra N. et al. (2022) Data Brief 43, 108415 Monoclonal antibodies binding data for SARS-CoV-2 proteins | More details |
| HEK-293T | in vitro | DNA | PEIpro | Rebendenne A. et al. (2022) Nat Genet 54, 1090-1102 Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs | More details |
| CHO-S, FreeStyle 293-F, Lec3.2.8.1 | in vitro | DNA | FectoCHO Expression System, FectoPRO | Samuelsson E. et al. (2022) ACS Infect Dis 8, 1883-1893 Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity | More details |
| Expi293F | in vitro | DNA | FectoPRO | He WT. et al. (2022) Sci Transl Med 14, eabl9605 Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques | More details |
| Expi293F | in vitro | DNA | FectoPRO | Sokal A. et al. (2022) Immunity 55, 1096-1104 Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant | More details |
| FreeStyle 293-F | in vitro | DNA | FectoPRO | Guo J. et al. (2022) J Med Virol 94, 3791-3800 Generation and characterization of humanized synergistic neutralizing antibodies against SARS-CoV-2 | More details |
| Expi293F | in vitro | DNA | FectoPRO | Gwyn S. et al. (2022) Am J Trop Med Hyg 107, 260–7 Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases | More details |
| HEK-293F | in vitro | DNA | FectoPRO | Rong Y. et al. (2022) ACS Infect Dis , Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions | More details |
| Expi293F | in vitro | DNA | FectoPRO | Weidenbacher PA. et al. (2022) Nat Chem Biol , Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors | More details |
| - | in vitro | DNA | FectoPRO | Weidenbacher P. et al. (2022) Biochemistry , Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development | More details |